USD/CAD Holds Steady Above 1.3500 as US Data Week Approaches: A Look at the Upcoming Market Activity

Trading Insights: USD/CAD Tight Range Above Psychological Support The USD/CAD pair trades in a tight range above the psychological support of 1.3500 in Tuesday’s European session. The Loonie asset turns sideways as investors await the United States (US) labor market and the Purchasing Managers’ Index (PMI) data, which will indicate whether the Federal Reserve (Fed)…

Read More

Unlocking Ethereum’s Potential: Breaking Down Key Levels for ETH to Reach New Heights

Ethereum (ETH) Facing Resistance Amid Market Downturn Market Analysis Ethereum (ETH), the second-largest cryptocurrency by market capitalization, has recently lagged behind other top tokens, posting losses on both a 24-hour and weekly basis. Despite this downturn, some analysts believe that if Ethereum can overcome critical resistance levels in the near future, it may follow seasonal…

Read More

Revolutionizing the Water Industry: H2O Innovation Acquires NextEra Distributed Water

Welcome to the Future of Wastewater Treatment and Reuse A New Venture for H2O Innovation Quebec City–(BUSINESS WIRE)–H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) today announced that it has acquired NextEra Distributed Water (the “Business”) via a carve-out transaction. Going forward, the Business and its portfolio of sustainable wastewater treatment and reuse projects will…

Read More

Discover the Latest Innovations: Inovio to Showcase at Upcoming Scientific Conferences

INOVIO Announces Participation in Scientific Conferences AACR Special Conference in Cancer Research INOVIO, a biotechnology company, will present a poster at the AACR Special Conference in Cancer Research on October 19, 2024. Dr. Matthew Morrow, VP of Translational Sciences at INOVIO, will present on the reduction in surgical interventions for the treatment of Recurrent Respiratory…

Read More

Goodbye Brain Tumor: BriaCell’s Breakthrough Treatment Resolves Eye-Bulging Metastasis in Breast Cancer Patient

Welcome to the Future of Cancer Care Exciting News from BriaCell Therapeutics Corp. PHILADELPHIA and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) BriaCell Therapeutics Corp. has just announced a groundbreaking development in the world of cancer treatment. In a recent Phase 2 study, a patient with temporal lobe breast cancer metastasis showed a dramatic…

Read More

Breaking News: Costamare Inc. Announces Quarterly Dividend for Preferred and Common Stock!

Cash Dividends Declared by Costamare Inc. MONACO, Oct. 01, 2024 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE PR B), US $0.531250 per share on its 8.50% Series…

Read More